Delivery Order SPE2DB22D3016-SPE2DB24FAHE0
Award Date 1/2/24
Potential Completion Date 1/24/24
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a delivery order (SPE2DB25FDR84) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division. The order is for the supply of 4,566,052,886 units of the IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical product. The award is a firm fixed-price contract with a ceiling value of $15,420.00 and an ultimate completion date of October 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a potential value of $7,710.00 and a completion date of March 11, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for IMFINZI 500 mg/10 mL vials, with a contract value of $2,652.56 and a completion date of November 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on October 20, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,305.14 for IMFINZI 500 mg/10 ml vials on August 25, 2025, with completion anticipated by September 16, 2025. This firm fixed price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $15,420.00 award is for the delivery of 500 mg/10 mL vials of the pharmaceutical product IMFINZI. The contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an...
- The Defense Logistics Agency (DLA) awarded a $44.8K delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 23, 2026, for the supply of IMFINZI 500 mg/10 mL vials. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 13, 2026, and performance at the contractor's facility in Conshohocken, Pennsylvania. IMFINZI (durvalumab) is an oncology pharmaceutical used in cancer treatment, consistent with AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,610.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 mg/10 mL vials of Imfinzi, an oncology pharmaceutical product. The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be fulfilled from the vendor's Conshohocken,...
- On January 21, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $44,792.40 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by February 11, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. The contract represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $33.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of IMFINZI (durvalumab) 500 mg/10 mL vials. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania, and completion targeted for January 21, 2026. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global...